TRAF3 and plasma cell myeloma: Reinforcing the evidence obtained from mouse models, somatic mutations (such as homozygous deletions and inactivating mutations) of the TRAF3 gene in humans were first identified in multiple myeloma (MM) and then other B cell malignancies (1, 3, 9–11).